Skip to content

Drug interactions

Buprenorphine subdermal implant + Escitalopram

Severity: Minor

Buprenorphine subdermal implant and Escitalopram: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Escitalopram and buprenorphine both have QT-prolonging potential, though the steady low buprenorphine exposure from an implant makes a clinically important effect less likely. Serotonergic additive effects are also possible but uncommon.

What this interaction means in plain words

Buprenorphine subdermal implant and Escitalopram have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible additive QTc prolongation; buprenorphine has weak serotonergic activity.

What to do

No routine change is needed; consider an ECG in patients with long QT syndrome, electrolyte disturbance or other QT-prolonging drugs, and counsel on serotonin toxicity symptoms.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Escitalopram, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine subdermal implant with Escitalopram?

MediHelp rates the interaction as minor. Buprenorphine subdermal implant and Escitalopram have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Escitalopram and buprenorphine both have QT-prolonging potential, though the steady low buprenorphine exposure from an implant makes a clinically important effect less likely. Serotonergic additive effects are also possible but uncommon.

How serious is the interaction between Buprenorphine subdermal implant and Escitalopram?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed; consider an ECG in patients with long QT syndrome, electrolyte disturbance or other QT-prolonging drugs, and counsel on serotonin toxicity symptoms.

What other medicines interact with Escitalopram?

MediHelp also lists interactions of Escitalopram with, for example, Cisapride, Citalopram, Isocarboxazid. The full list is on the Escitalopram page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in